Interventional Neuroradiology

Neuro Suite

All Interventional neurology in one room

Philips introduces the Neuro Suite featuring the Allura FD20/15 interventional X-ray system. This integrated solution is designed to enhance your treatment capabilities and support more effective device guidance and placement in every procedure.

Contact information

* This field is mandatory
*

Contact details

*
*
*

Company details

*
*
*
*
*

Business details

By specifying your reason for contact we will be able to provide you with a better service.
*
*
Features
AlluraClarity with ClarityIQ:Achieve 73% reduction in dose
AlluraClarity with ClarityIQ:Achieve 73% reduction in dose

AlluraClarity with ClarityIQ:Achieve 73% reduction in dose

A clinical study from Karolinska University Hospital, Sweden proved that AlluraClarity with ClarityIQ technology can reduce the patient entrance dose by 73% for digital subtraction neuro-angiographic exams, without a loss of image quality.
Next generation 16 bit flat detectors:Never before seen details
Next generation 16 bit flat detectors:Never before seen details

Next generation 16 bit flat detectors:Never before seen details

AlluraClarity FD20/15 pairs a 20 inch 16 bit detector with a 15 inch 16 bit lateral flat detector. This technology makes the intricacies of complex malformations & less radio-opaque flow diverters and intra saccular devices fully visible.
PerfectFit FD20/15 detector design:Full access and brain coverage
PerfectFit FD20/15 detector design:Full access and brain coverage

PerfectFit FD20/15 detector design:Full access and brain coverage

The PerfectFit design allows the FD15 detector to be positioned close to the patient’s head, covering the head from Cranium to Cervical 3*. This results in high quality images at low X-ray dose.* In 95% of the patient population.
AneurysmFlow: Enhances insight into cerebral aneurysm
AneurysmFlow: Enhances insight into cerebral aneurysm

AneurysmFlow: Enhances insight into cerebral aneurysm

AneurysmFlow is designed to provide relevant information right after deployment based on quantification of blood flow changes. This supports clinicians in assessing the impact of devices, such as flow diverters, on blood flow right away.